Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors

Patent 9890156 was granted and assigned to Incyte on February, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 29 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
Edits on 7 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Article (+232 characters)
Article

Patent abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.

Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Ding-Quan Qian0
Liang Lu0
Liangxing Wu0
Wenqing Yao0
Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors
0
Edits on 17 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09890156 Bicyclic heterocycles as FGFR4 inhibitors US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors

Infobox
Patent Number
098901560
Patent Number
98901560
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
098901560
Date of Patent
February 13, 2018
0
Patent Application Number
150478760
Date Filed
February 19, 2016
0
Patent Primary Examiner
‌
Leslie A. Royds Draper
0
Edits on 18 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 18 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09890156 Bicyclic heterocycles as FGFR4 inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Incyte
Incyte
Current assignee
Incyte
Incyte
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09890156
Date of patent
February 13, 2018
Patent application number
15047876
Date Filed
February 19, 2016
Patent primary examiner
‌
Leslie A. Royds Draper

Find more entities like US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo